Insights from 2023 EHA® Annual Meeting

 

MDS and MPN
12:44

Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Disease-Modifying Activity of Navtemadlin Correlated With Survival Outcomes in JAKi R/R Myelofibrosis Patients"

FEATURING Pankit Vachhani
  • 115 views
  • June 20, 2023
  • 1